Patient#	Sample#	ACTL6A:(ACTL6A, protein),	FBXW7:(FBXW7, protein),	HBP1:(HBP1, protein),	PAK2:(PAK2, protein),	PML4:(PML4, protein),	SKP2:(SKP2, protein),	SPT3:(SPT3, protein),	TAF10:(TAF10, protein),	TAF12:(TAF12, protein),	TAF9:(TAF9, protein),	ZBTB17:(ZBTB17, protein),	p14ARF:(p14ARF, protein),	MYC/Max:(Axin1/GSK3beta/PIN1/PP2A-B56alpha, active),(FBXW7, active),(Fbw7-alpha/USP28, active),(SKP2, active),	SUPT7L:(SUPT7L, protein),	MAX:(MAX, protein),(MYC/Max, active),	MYC:(MYC, protein),(MYC/Max, active),(PAK2, active),(response to stress, active),	MYC/Max/DNA replication preinitiation complex:(DNA replication preinitiation complex, active),(MYC/Max, active),	MYC/Max/HBP1:(HBP1, active),(MYC/Max, active),	MYC/Max/MIZ-1:(MYC/Max, active),(ZBTB17, active),	MYC/Max/P-TEFb:(MYC/Max, active),(positive transcription elongation factor complex b, active),	MYC/Max/PML4:(MYC/Max, active),(PML4, active),	MYC/Max/TRRAP/GCN5/STAF65G/SPT3/TAF9/TAF10/TAF12/core Mediator:(MYC/Max, active),(SPT3, active),(SUPT7L, active),(TAF10, active),(TAF12, active),(TAF9, active),(TRRAP/GCN5, active),(core mediator complex, active),	MYC/Max/TRRAP/TIP60/TIP49A/TIP49B/BAF53:(ACTL6A, active),(MYC/Max, active),(TIP49A/TIP49B, active),(TRRAP/TIP60, active),	MYC/Max/p14ARF:(MYC/Max, active),(p14ARF, active),	proteasomal ubiquitin-dependent protein catabolic process:(MYC/Max, active),	
